Your browser doesn't support javascript.
loading
UHPLC-MS/MS method for simultaneous quantification of doripenem, meropenem, ciprofloxacin, levofloxacin, pazufloxacin, linezolid, and tedizolid in filtrate during continuous renal replacement therapy.
Kai, Makoto; Tanaka, Ryota; Suzuki, Yosuke; Goto, Koji; Ohchi, Yoshifumi; Yasuda, Norihisa; Tatsuta, Ryosuke; Kitano, Takaaki; Itoh, Hiroki.
Afiliação
  • Kai M; Department of Clinical Pharmacy, Oita University Hospital, Yufu, Japan.
  • Tanaka R; Department of Clinical Pharmacy, Oita University Hospital, Yufu, Japan.
  • Suzuki Y; Department of Clinical Pharmacy, Oita University Hospital, Yufu, Japan.
  • Goto K; Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Tokyo, Japan.
  • Ohchi Y; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Oita University, Yufu, Japan.
  • Yasuda N; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Oita University, Yufu, Japan.
  • Tatsuta R; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Oita University, Yufu, Japan.
  • Kitano T; Department of Clinical Pharmacy, Oita University Hospital, Yufu, Japan.
  • Itoh H; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Oita University, Yufu, Japan.
J Clin Lab Anal ; 37(1): e24815, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36525363

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levofloxacino / Terapia de Substituição Renal Contínua Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Clin Lab Anal Assunto da revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Levofloxacino / Terapia de Substituição Renal Contínua Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Clin Lab Anal Assunto da revista: TECNICAS E PROCEDIMENTOS DE LABORATORIO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão